The metabolic risk profile of breast cancer survivors 2 to 6 months post-chemotherapy.

e19612 Background: Overweight and obesity are associated with poor outcomes for patients with breast cancer. Physical inactivity coupled with weight gain during treatment place breast cancer survivors at risk of developing obesity related problems including the metabolic syndrome (MetSyn). We report baseline findings of an ancillary study to an ongoing randomised controlled trial (PEACH trial) (Walsh J.M. et al. 2010 Pragmatic Randomized Trial of Individually Prescribed Exercise versus Usual Care in Heterogeneous Cancer Survivor Population. A Feasibility Study. PEACH: Prescribed Exercise After Chemotherapy. BMC Cancer. 10[42]) examining the effect of exercise on the metabolic risk profile of breast cancer survivors, 2-6 months post chemotherapy. Methods: Breast cancer survivors who consented to partake in the PEACH trial were requested to participate. The five clinical features of the MetSyn were measured: waist circumference, resting blood pressure, triglycerides, high-density lipoprotein cholesterol and...